Complications of Intravitreous Injections in Patients with Diabetes.

Aditi Gupta, Jennifer K Sun, Paolo S Silva

Journal: Seminars in ophthalmology 2018;33(1):42-50

PMID: 29420143

Abstract

Intravitreous injections are presently the second most frequently performed ophthalmic procedure and the most common vitreoretinal procedure. In diabetic patients, intravitreous injections are frequently performed for the treatment of center-involved diabetic macular edema, proliferative diabetic retinopathy, or other co-existing retinal vascular disease. Diabetic patients may be at higher risk of adverse events compared to non-diabetic individuals, given frequent systemic comorbidities, such as cardiovascular and renal disease and increased susceptibility to infection. This review highlights the potential complications and safety considerations in intravitreous injections in patients with diabetes.

Address: a Beetham Eye Institute, Joslin Diabetes Center , Boston , MA , USA.; b Department of Ophthalmology , Harvard Medical School , Boston , MA , USA.

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.